Aphthous Stomatitis

rgb(153,198,190)
Last updated February 24, 2015
Case Authors: 
Christopher Behrens, MD
Clinical Assistant Professor
Department of Global Health, Family Medicine, and Medicine
University of Washington School of Medicine 
Learning Objectives: 
  1. Describe how aphthous lesions in HIV-infected patients can differ from aphthous lesions in immunocompetent HIV-negative persons.
  2. List agents that have efficacy in the management of aphthous lesions in HIV-infected persons.

Display Group

References
  1. Greenspan D, Canchola AJ, MacPhail LA, Cheikh B, Greenspan JS. Effect of highly active antiretroviral therapy on frequency of oral warts. Lancet. 2001;357:1411-2.
  2. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol. 2003;4:669-80.
  3. Natah SS, Häyrinen-Immonen R, Hietanen J, Malmström M, Konttinen YT. Immunolocalization of tumor necrosis factor-alpha expressing cells in recurrent aphthous ulcer lesions (RAU). J Oral Pathol Med. 2000;29:19-25.
  4. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of recurrent aphthous stomatitis: a consensus approach. J Am Dent Assoc. 2003;134:200-7.
  5. Greenspan D, Greenspan JS. HIV-related oral disease. Lancet. 1996;348:729-33.
  6. MacPhail LA, Greenspan D, Feigal DW, Lennette ET, Greenspan JS. Recurrent aphthous ulcers in association with HIV infection. Description of ulcer types and analysis of T-lymphocyte subsets. Oral Surg Oral Med Oral Pathol. 1991;71:678-83.
  7. Rogers RS 3rd. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg. 1997;16:278-83.
  8. Ficarra G. Oral ulcers in HIV-infected patients: an update on epidemiology and diagnosis. Oral Dis. 1997;3 Suppl 1:S183-9.
  9. Dalmau J, Alegre M, Domingo P, Alomar A. Major oral aphtous ulceration in HIV-1 infection: successful response after highly active antiretroviral therapy. J Eur Acad Dermatol Venereol. 2007;21:126-7.
  10. Alegre M, Dalmau J, Domingo P, Roé E, Alomar A. Successful treatment of major oral aphthous ulcers in HIV-1 infection after highly active antiretroviral therapy. Int J Infect Dis. 2006;11:278-9.
  11. MacPhail LA, Greenspan D, Greenspan JS. Recurrent aphthous ulcers in association with HIV infection. Diagnosis and treatment. Oral Surg Oral Med Oral Pathol. 1992;73:283-8.
  12. Ship JA. Recurrent aphthous stomatitis. An update. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996;81:141-7.
  13. Barrons RW. Treatment strategies for recurrent oral aphthous ulcers. Am J Health Syst Pharm. 2001;58:41-50.
  14. Shetty K. Thalidomide in the management of recurrent aphthous ulcerations in patients who are HIV-positive: a review and case reports. Spec Care Dentist. 2005;25:236-41.
  15. Jacobson JM, Greenspan JS, Spritzler J, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med. 1997;336:1487-93.
  16. Jacobson JM, Spritzler J, Fox L, et al. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. J Infect Dis. 1999;180:61-7.